Key points
- There is no specific treatment for eastern equine encephalitis; clinical management is supportive.
- Monitor patients closely for severe complications.
- Counsel patients about using personal protective measures to prevent mosquito bites.
Treatment
There is no specific treatment for eastern equine encephalitis; clinical management is supportive. Patients with severe meningeal symptoms often require pain control for headaches and antiemetic therapy and rehydration for associated nausea and vomiting. Patients with encephalitis require close monitoring for the development of elevated intracranial pressure, seizures, and inability to protect their airway.
Prevention
No eastern equine encephalitis virus vaccines are available for use in humans. In the absence of a vaccine, prevention of eastern equine encephalitis depends on personal protective measures to decrease exposure to infected mosquitoes. This includes using insect repellent, wearing long-sleeved shirts and pants, treating clothing and gear with 0.5% permethrin, and taking steps to control mosquitoes indoors and outdoors. More information about preventing mosquito bites can be found on the CDC Mosquitoes website.
Eastern equine encephalitis virus has been documented to be transmitted through solid organ transplantation and likely can be transmitted through blood transfusions. People recently diagnosed with eastern equine encephalitis should not donate blood for 120 days (4 months) after their illness.
Eastern equine encephalitis virus infections temporally associated with organ transplantation or blood transfusion should be reported promptly to the appropriate state or local health department.
- Pouch SM, Katugaha SB, Shieh WJ, Annambhotla P, Walker WL, Basavaraju SV, et. al. Transmission of eastern equine encephalitis virus from an organ donor to 3 transplant recipients. Clin Infect Dis. 2019;69(3):450-458. doi: 10.1093/cid/ciy923
- Armstrong PM, Andreadis TG. Eastern equine encephalitis virus in mosquitoes and their role as bridge vectors. Emerg Infect Dis. 2010;16(12):1869-1874. doi: 10.3201/eid1612.100640